SOD1 and amyotrophic lateral sclerosis: SOD1 mutations have been the first molecular defects described in fALS forms with dominant inheritance (Rosen et al., 1993) and most of the research studies addressing ALS pathogenesis and the development of therapeutic strategies have been performed using SOD1 transgenic models (Gurney et al., 1994).